47 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Nov 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
44
Ending by 2030
Nov 2027
Next term end
3
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends no later than Oct 2029 · Medium confidence
Also notable
Ends Nov 2038 · High confidence
Also notable
Ends Feb 2039 · High confidence
Drug Releasing Coatings for Medical Devices
US 8,414,909
The most cited patent in this portfolio, cited by 286 later US patents, top 5% of utility patents granted in 2013 in our data. Protection runs to 2029. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Medical Device with Drug-Eluting Coating on Modified Device Surface
US 11,541,152
The newest of the three, granted 2023. It anchors the portfolio to 2038, later than anything else here.
Balloon Protectors, Balloon-Catheter Assemblies, And Methods Thereof
US 11,389,627
Granted 2022. Computed term ends 2039.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 10, 2027The maintenance fee for Methods and Apparatuses for Coating Balloon Catheters (US 9,180,485) comes due May 10, 2027. Unpaid by Nov 10, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 2 largest of its 3 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Drug Releasing Coatings for Medical Devices | 45 in force | to Oct 2031 |
| Medical Device with Drug-Eluting Coating on Modified Device Surface | 1 in force | to Nov 2038 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,241,249 | Drug Releasing Coatings for Medical Devices In force · High confidence | In force | High confidence | |
| US 8,244,344 | Drug Releasing Coatings for Medical Devices In force · High confidence | In force | High confidence | |
| US 8,366,660 | Drug Releasing Coatings for Medical Devices In force · Medium confidence | In force | Medium confidence | |
| US 8,366,662 | Drug Releasing Coatings for Medical Devices In force · Medium confidence | In force | Medium confidence | |
| US 8,403,910 | Drug Releasing Coatings for Medical Devices In force · Medium confidence | In force | Medium confidence | |
| US 8,404,300 | Drug Releasing Coatings for Medical Devices In force · Medium confidence | In force | Medium confidence | |
| US 8,414,910 | Drug Releasing Coatings for Medical Devices In force · Medium confidence | In force | Medium confidence | |
| US 8,932,561 | Medical Device Rapid Drug Releasing Coatings Comprising a Therapeutic Agent and a Contrast Agent In force · Medium confidence | In force | Medium confidence | |
| US 8,998,847 | Drug Releasing Coatings for Medical Devices In force · Low confidence | In force | Low confidence | |
| US 9,005,161 | Drug Releasing Coatings for Medical Devices In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 47: 1 application pending · 8 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.